#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma Chronic graft versus host disease in intestine Nephroblastoma Osteosarcoma metastatic Shprintzen-Goldberg syndrome X-linked lymphoproliferative syndrome Urethral valves Congenital megacolon Ewing's sarcoma metastatic Peripheral primitive neuroectodermal tumour of soft tissue Neuroendocrine carcinoma metastatic Congenital cystic kidney disease Haemophilia B with anti factor IX ABO haemolytic disease of newborn Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Treatment Crigler-Najjar syndrome – Diagnostics Leiomyosarcoma metastatic – Trials in Disease Piriformis syndrome – Trials in Disease Turner’s syndrome – Treatment Angiosarcoma X-linked lymphoproliferative syndrome – Basic Information Congenital hypotransferrinaemia – Life with Disease Haemophilia B without inhibitors – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lu Ag09222 Mosaic Hbcoreag AZD4360 VX-993 Tucidinostat Carbetocin RO7288817 Glepaglutide ACT-1004-1239 Flecainide Acetate Gliquidone Cimetidine Hydrochloride Follitropin Beta Gozetotide Clebopride Hydrogen Maleate Amsacrine Bnt314 Nedosiran PALAZESTRANT Perindopril Arginine More therapies…

    Learn about Your Condition

    Endocarditis Burkitt's lymphoma Systemic lupus erythematosus Oral neoplasm ROHHAD syndrome Cerebrovascular accident Reperfusion injury Polymyalgia rheumatica Double hit lymphoma Food allergy Epstein-Barr virus infection Metastatic gastric cancer Acarodermatitis Soft tissue sarcoma Idiopathic pulmonary fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Sorafenib
    • Ipilimumab
    • Lenvatinib
    Austria Belgium France Germany Italy Poland +2

  • Study on the Safety and Effects of Englumafusp Alfa with Obinutuzumab and Glofitamab for Patients with Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell lymphoma refractory
    • B-cell lymphoma
    Investigated Drugs:
    • Englumafusp Alfa
    • Glofitamab
    • Obinutuzumab
    Belgium Denmark France Italy Spain

  • Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Rosnilimab
    Belgium Estonia France Germany Hungary Italy +3

  • Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    • Pembrolizumab
    Austria Belgium Czechia France Germany Hungary +6

  • Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Dexamethasone
    • Gemcitabine
    Belgium Czechia France Hungary Italy The Netherlands +2

  • Study on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)

    Not recruiting

    2 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    Investigated Drugs:
    • Gsk4532990A
    Belgium France Greece Italy Spain

  • Study on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Acute graft versus host disease
    Investigated Drugs:
    • Allogeneic Mesenchymoangioblast-Derived Mesenchymal Stem Cells
    France Italy Lithuania Spain

  • Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Capecitabine
    • Carboplatin
    • Cyclophosphamide
    Austria Belgium Bulgaria France Germany Hungary +3

  • Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Camizestrant
    • Goserelin Acetate
    Austria Belgium Bulgaria Czechia France Germany +7

  • Study on Durvalumab and Chemotherapy for Patients with Advanced Biliary Tract Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary tract disorder
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    France Germany Italy Spain
Previous Page
1 … 48 49 50 51 52 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!